98%
921
2 minutes
20
Introduction: Fatigue is the most common and disabling symptom in multiple sclerosis (MS), being reported by 55% to 78% of patients with MS (PwMS). Etiology of MS-related fatigue remains poorly understood, but an increased neuromuscular fatigability (i.e., greater loss of torque during exercise) could contribute to this phenomenon. This study aimed to characterize the correlates of MS-related fatigue in PwMS using a comprehensive group of physiological and psychosocial measures, with a particular focus on fatigability.
Methods: Forty-two relapsing-remitting PwMS and 20 healthy subjects were recruited. PwMS were assigned in two groups (high (HF) and low (LF) fatigue) based on two fatigue questionnaires (Fatigue Severity Scale and Modified Fatigue Impact Scale). The main outcomes of this study are derived from incremental cycling completed to task failure (i.e., inability to pedal around 60 rpm). Maximal voluntary contraction (MVC), rating of perceived exertion, and central and peripheral parameters measured using transcranial magnetic and peripheral nerve stimulation were assessed in the knee extensor muscles before, during, and after the fatiguing task. Other potential correlates of fatigue were also tested.
Results: MVC torque decreased to a greater extent for the HF group than LF group after the third common stage of the incremental fatiguing exercise (-15.7% ± 6.6% vs -5.9% ± 13.0%, P < 0.05), and this occurred concurrently with a higher rating of perceived exertion for HF (11.8 ± 2.5 vs 9.3 ± 2.6, P < 0.05). Subjective parameters (depression, quality of life) were worse for HF compared with LF and healthy subjects ( P < 0.001). Moreover, MVC torque loss at the final common stage and maximal heart rate explained 29% of the variance of the Modified Fatigue Impact Scale.
Conclusions: These results provide novel insight into the relationship between MS-related fatigue and fatigability among PwMS. The HF group exhibited greater performance fatigability, likely contributing to a higher perceived exertion than the LF group when measured during a dynamic task.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1249/MSS.0000000000003233 | DOI Listing |
Patient
August 2025
National Centre for Epidemiology and Population Health, The Australian National University, Building 63A, Acton, ACT, 2601, Australia.
Background: Fatigue is one of the most prevalent and debilitating symptoms of multiple sclerosis (MS), as people with MS describe it. It has a complex pathogenesis and often precedes the clinical symptoms of MS and potentially indicates disease progression. Given its prevalence, impact, and intricate connections to disease pathology, accurate measurement is crucial to manage and study fatigue in people with MS; however, current measurements often lack content validity.
View Article and Find Full Text PDFMetabolomics
August 2025
Laboratories of Neuroimmunology, Department of Clinical Neurosciences, Center for Research in Neuroscience and Service of Neurology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Introduction: Multiple sclerosis (MS) is an autoimmune disorder with an unpredictable outcome at the time of diagnosis. The measurement of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) has introduced new biomarkers for assessing MS disease activity and progression. However, there is a need for additional diagnostic and prognostic tools.
View Article and Find Full Text PDFMult Scler Relat Disord
July 2025
Ege University, Faculty of Medicine, Department of Neurology, 35100, İzmir, Turkey. Electronic address:
Background: Dual-task training has gained attention in neurological rehabilitation, yet its effectiveness remains uncertain due to methodological differences, emphasizing the need for standardized assessments to clarify its impact on Multiple Sclerosis (MS)-related motor and cognitive deficits. This study aimed to examine the effects of motor-motor and motor-cognitive dual-task training on walking ability, walking speed, balance, functional mobility, dual-task difficulties, cognitive function, and fatigue in people with Multiple Sclerosis (pwMS).
Method: This randomized controlled trial included 32 pwMS meeting the inclusion criteria.
PLoS One
July 2025
Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Background: Fatigue is a prevalent symptom in people with Multiple Sclerosis, but evidence for the effectiveness of telemedicine in treating this symptom remains incomplete. Despite favorable clinical trial results, its integration into practice and systematic evaluation is limited.
Objective: The purpose of this research project is to carefully assess how well telemedicine works for managing fatigue in MS patients.
Mult Scler Relat Disord
September 2025
Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Introduction: Multiple sclerosis (MS) is a chronic, progressive neurological disorder characterized by inflammation, demyelination, and neurodegeneration of the central nervous system. Globally, it affects approximately 2.8 million people, often leading to significant disability and impaired quality of life.
View Article and Find Full Text PDF